Ivermectin Availability, Product Information & Purchase Options
Ivermectin is a well-characterized antiparasitic compound in the avermectin class of macrocyclic lactones. This page provides factual background on its chemistry, registered formulations, how legal status differs by jurisdiction, and what to look for when evaluating product listings. It does not substitute for guidance from a licensed healthcare professional.
What Is Ivermectin?
Ivermectin (CAS 70288-86-7) is derived from fermentation products of the soil bacterium Streptomyces avermitilis. First described in the late 1970s and introduced to human clinical use in the 1980s, it works by potentiating glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, causing paralysis and death of susceptible parasites. Mammalian cells carry a different receptor profile, which underpins the compound's selective toxicity at approved doses.
The World Health Organization added ivermectin to its Model List of Essential Medicines in 1987, initially for onchocerciasis control programs. It has since become a cornerstone of neglected tropical disease (NTD) elimination efforts in endemic regions worldwide.
Note: This page covers compound details and product availability. It is not a substitute for professional medical guidance. Always consult a licensed healthcare provider or pharmacist about any specific health concern.
Available Formulations & Strengths
Several ivermectin formulations have been evaluated by regulatory agencies for specific indications. The table below summarizes the major registered forms. Approval in one jurisdiction does not imply approval in another.
| Formulation | Strength | Example Brand (US) | Registered Indication Area |
|---|---|---|---|
| Oral tablet | 3 mg | Stromectol® | Intestinal strongyloidiasis; onchocerciasis |
| Oral tablet (generic) | 3 mg, 6 mg | Various generics | Bioequivalent to Stromectol® |
| Topical cream | 1% w/w | Soolantra® | Inflammatory lesions of rosacea |
| Topical lotion | 0.5% w/w | Sklice® | Head lice infestation |
Full prescribing information for US-registered products is publicly available via the FDA DailyMed database, which hosts the most current approved labeling for each product.
Regulatory Status & Regional Availability
Ivermectin's legal status varies considerably by region. Anyone researching sourcing options should verify the status applicable to their own jurisdiction before making any decisions. Our regional availability page covers this in detail by market.
In the United States, oral ivermectin is an FDA-approved compound (NDA 050742) and is not classified as an over-the-counter product. In the European Union, topical formulations hold centralized EMA authorizations; oral formulations for human use are authorized at the national level in certain member states. In Australia, the TGA classifies oral tablets as Schedule 4 (requires a licensed practitioner's order). In several low- and middle-income countries participating in WHO-supported NTD programs, community-directed distribution occurs under public health frameworks, with dispensing requirements varying by context.
Regional verification: The WHO Essential Medicines documentation and each national regulatory body's public database are the most reliable sources for current approval status in a given country.
Comparing Product Listings
Searches for ivermectin products return listings from a variety of sources — international pharmacies, compounding services, and resellers. Quality and authenticity vary. When evaluating a listing, the following factors are worth examining:
- Manufacturer identity: Is the product made by a licensed pharmaceutical manufacturer? Look for a named company with verifiable regulatory registrations.
- Stated strength and formulation: Confirm the label specifies strength (e.g., 3 mg tablet) matching what clinical guidance describes.
- Lot and expiry documentation: Legitimate pharmaceutical products carry batch numbers, manufacturing dates, and expiry dates that can be checked against manufacturer records.
- Dispensing jurisdiction: Understand the regulatory framework under which the vendor operates. The legal context differs materially depending on where the vendor is licensed.
- Pharmacist involvement: Some platforms require a pharmacist review step, adding a layer of professional oversight to the process.
Important: Acquiring pharmaceutical products from unverified sources carries risks including counterfeit product, incorrect dosing, and absence of appropriate professional oversight. Consult a healthcare provider or pharmacist before making any sourcing decisions.